CXCL12/CXCR4 transactivates members of growth factor receptor in PC cells [3, 6], and expression of HER2 in PC patients correlates with tumor cell proliferation [43] and activates androgen receptor signaling in advanced disease [44]. Here, CXCR4 is linked to pachyonychia congenita.